Información del personal investigador

Portal del Investigador > Personal investigador > detalle investigador

DAVID MAESTRO LAVIN

Publicaciones
5
Proyectos
4

david.maestro@unican.es

Edificio IBBTEC. c/ Albert Einstein, 22 (PCTCAN). 39011 Santander

Programa Margarita Salas

Programa de Doctorado en Biología Molecular y Biomedicina por la Universidad de Cantabria

INST. DE BIOMEDICINA Y BIOTECNOLOGÍA DE CANTABRIA

Identificadores

Publicaciones Proyectos

Exportar: Bib

5 resultados

Epigenetic alterations of TGFß and its main canonical signaling mediators in the context of cardiac fibrosis

Artículo de Revista

Journal of Molecular and Cellular Cardiology. Volume 159, October 2021, Pages 38-47

Autoría: LUIS ALGECIRAS JIMÉNEZ, ANA ROSA PALANCA CUÑADO, DAVID MAESTRO LAVIN, JORGE RUIZ DEL RIO, ANA VICTORIA VILLAR RAMOS

2021

Correlative 3D cryo X-ray imaging reveals intracellular location and effect of designed antifibrotic protein-nanomaterial hybrids

Artículo de Revista

Chemical Science, 2021, 12(45), 15090-15103

Autoría: J. GROEN, ANA ROSA PALANCA CUÑADO, A. AIRES, J.J. CONESA, DAVID MAESTRO LAVIN, S. REHBEIN, M. HARKIOLAKI, ANA VICTORIA VILLAR RAMOS, A.L. CORTAJARENA, E. PEREIROA

19/10/2021

Engineering multifunctional metal/protein hybrid nanomaterials as tools for therapeutic intervention and high-sensitivity detection

Artículo de Revista

Chemical Science, 2021,12, 2480-2487

Autoría: ANTONIO AIRES, DAVID MAESTRO LAVIN, JORGE RUIZ DEL RIO, ANA ROSA PALANCA CUÑADO, ELENA LÓPEZ MARTÍNEZ, IRANTZU LLARENA, KALOTINA GERAKI, CARLOS SÁNCHEZ CANO, ANA VICTORIA VILLAR RAMOS, AITZIBER L. CORTAJARENA

2021

Reduction of Cardiac TGFß-mediated Profibrotic Events by Inhibition of Hsp90 With Engineered Protein

Artículo de Revista

J Mol Cell Cardiol , 123, 75-87 Oct 2018

Autoría: R A CÁCERES, T CHAVEZ, DAVID MAESTRO LAVIN, ANA ROSA PALANCA CUÑADO, P BOLADO, F. MADRAZO, A. AIRES, A.L. CORTAJARENA, ANA VICTORIA VILLAR RAMOS

2018

Newly experimental designed CTPR390-488 biosynthetic nanoparticle as a potential biomarker-drug of myocardial fibrosis

Comunicación a Congreso

Cardiovascular Research, 2018, 114(S1), S37

Autoría: ANA ROSA PALANCA CUÑADO, DAVID MAESTRO LAVIN, RA. CACERES, T. CHAVEZ, A. AIRES, AL. CORTAJARENA, ANA VICTORIA VILLAR RAMOS

2018

5 resultados

Volver

Estamos realizando la búsqueda. Por favor, espere...

Researchers portal

Portal del personal investigador

DAVID MAESTRO LAVIN

Identificadores

Epigenetic alterations of TGFß and its main canonical signaling mediators in the context of cardiac fibrosis

Correlative 3D cryo X-ray imaging reveals intracellular location and effect of designed antifibrotic protein-nanomaterial hybrids

Engineering multifunctional metal/protein hybrid nanomaterials as tools for therapeutic intervention and high-sensitivity detection

Reduction of Cardiac TGFß-mediated Profibrotic Events by Inhibition of Hsp90 With Engineered Protein

Newly experimental designed CTPR390-488 biosynthetic nanoparticle as a potential biomarker-drug of myocardial fibrosis